Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Clinical & Experimental Metastasis|March 24, 2021
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?P Ivanyi, T Park-Simon, H Christiansen, et al.
Pediatric Research|September 12, 2020
Preterm children's long-term academic performance after adaptive computerized training: an efficacy and process analysis of a randomized controlled trialJulia Jaekel, Katharina M Heuser, Antonia Zapf, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 11, 2024
Adaption of Follow-Up Visits for Preterm and High-Risk Children for Video ConsultationsAnne-Kathrin Dathe, Sandra Greve, Uta Teschler, et al.
Leukemia|April 1, 1997
Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative studyI Pichová, J Weber, J Litera, et al.
Leukemia|July 1, 2017
Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemiaM Mingay, A Chaturvedi, M Bilenky, et al.
Leukemia|June 25, 2014
Constitutive IRF8 expression inhibits AML by activation of repressed immune response signalingA Sharma, H Yun, N Jyotsana, et al.
European Journal of Biochemistry|January 15, 1998
Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinaseJ Konvalinka, J Litera, J Weber, et al.
Blood Cancer Journal|September 30, 2017
Meis2 as a critical player in MN1-induced leukemiaC K Lai, G L Norddahl, T Maetzig, et al.
Leukemia|June 9, 2006
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksF J T Staal, G Cario, G Cazzaniga, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Pageof 13